{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T16:00:53Z","timestamp":1793635253741,"version":"4.5.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T00:00:00Z","timestamp":1594598400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T00:00:00Z","timestamp":1594598400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Human umbilical cord mesenchymal stem cell (hUC-MSC) therapy is considered as a promising approach in the treatment of intrauterine adhesions (IUAs). Considerable researches have already detected hUC-MSCs by diverse methods. This paper aims at exploring the quantitative distribution of CM-Dil-labeled hUC-MSCs in different regions of the uterus tissue of the dual injury-induced IUAs in rats and the underlying mechanism of restoration of fertility after implantation of hUC-MSCs in the IUA model.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>In this study, we investigated the quantification of the CM-Dil-labeled hUC-MSCs migrated to the dual injured uterus in Sprague Dawley rats. Additionally, we investigated the differentiation of CM-Dil-labeled hUC-MSCs. The differentiation potential of epithelial cells, vascular endothelial cells, and estrogen receptor (ER) cells were assessed by an immunofluorescence method using CK7, CD31, and ER\u03b1. The therapeutic impact of hUC-MSCs in the IUA model was assessed by hematoxylin and eosin, Masson, immunohistochemistry staining, and reproductive function test. Finally, the expression of TGF-\u03b21\/Smad3 pathway in uterine tissues was determined by qRT-PCR and Western blotting.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>The CM-Dil-labeled cells in the stroma region were significantly higher than those in the superficial myometrium (SM) (71.67\u2009\u00b1\u20097.98 vs. 60.92\u2009\u00b1\u20093.96, <jats:italic>p<\/jats:italic>\u2009=\u20090.005), in the seroma (71.67\u2009\u00b1\u20097.98 vs. 23.67\u2009\u00b1\u20098.08, <jats:italic>p<\/jats:italic>\u2009=\u20090.000) and in the epithelium (71.67\u2009\u00b1\u20097.98 vs. 4.17\u2009\u00b1\u20091.19, <jats:italic>p<\/jats:italic>\u2009=\u20090.000). From the 2nd week of treatment, hUC-MSCs began to differentiate into epithelial cells, vascular endothelial cells, and ER cells. The therapeutic group treated with hUC-MSCs exhibited a significant decrease in fibrosis (TGF-\u03b21\/Smad3) as well as a significant increase in vascularization (CD31) compared with the untreated rats.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Our findings suggested that the distribution of the migrated hUC-MSCs in different regions of the uterine tissue was unequal. Most cells were in the stroma and less were in the epithelium of endometrium and gland. Injected hUC-MSCs had a capacity to differentiate into epithelial cells, vascular endothelial cells, and ER cells; increase blood supply; inhibit fibration; and then restore the fertility of the IUA model.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13287-020-01806-4","type":"journal-article","created":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T11:04:10Z","timestamp":1594638250000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Quantification of the CM-Dil-labeled human umbilical cord mesenchymal stem cells migrated to the dual injured uterus in SD rat"],"prefix":"10.1186","volume":"11","author":[{"given":"Jia-Hua","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Kun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-Sheng","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Biao","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang-Dan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Bo","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Nan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-le","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Hua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,13]]},"reference":[{"key":"1806_CR1","first-page":"229","volume":"16","author":"S Bhandari","year":"2015","unstructured":"Bhandari S, Bhave P, Ganguly I, Baxi A, Agarwal P. Reproductive outcome of patients with Asherman\u2019s syndrome: a SAIMS experience. J Reprod Infertil. 2015;16:229\u201335.","journal-title":"J Reprod Infertil"},{"key":"1806_CR2","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/1477-7827-11-118","volume":"11","author":"A Conforti","year":"2013","unstructured":"Conforti A, Alviggi C, Mollo A, De Placido G, Magos A. The management of Asherman syndrome: a review of literature. Reprod Biol Endocrinol. 2013;11:118.","journal-title":"Reprod Biol Endocrinol"},{"key":"1806_CR3","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1159\/000486674","volume":"83","author":"H Liu","year":"2018","unstructured":"Liu H, Xu Y, Yi N, Yi W. Efficacy and safety of hyaluronic acid gel for the prevention of intrauterine adhesion: a meta-analysis of randomized clinical trials. Gynecol Obstet Investig. 2018;83:227\u201333.","journal-title":"Gynecol Obstet Investig"},{"key":"1806_CR4","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1055\/s-0034-1376358","volume":"32","author":"EA Evans-Hoeker","year":"2014","unstructured":"Evans-Hoeker EA, Young SL. Endometrial receptivity and intrauterine adhesive disease. Semin Reprod Med. 2014;32:392\u2013401.","journal-title":"Semin Reprod Med"},{"key":"1806_CR5","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.fertnstert.2012.06.032","volume":"98","author":"H Fernandez","year":"2012","unstructured":"Fernandez H, Peyrelevade S, Legendre G, Faivre E, Deffieux X, Nazac A. Total adhesions treated by hysteroscopy: must we stop at two procedures? Fertil Steril. 2012;98:980\u20135.","journal-title":"Fertil Steril"},{"key":"1806_CR6","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13287-018-0777-5","volume":"9","author":"L Zhang","year":"2018","unstructured":"Zhang L, Li Y, Guan CY, et al. Therapeutic effect of human umbilical cord-derived mesenchymal stem cells on injured rat endometrium during its chronic phase. Stem Cell Res Ther. 2018;9:36.","journal-title":"Stem Cell Res Ther"},{"key":"1806_CR7","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.actbio.2019.05.012","volume":"92","author":"L Xin","year":"2019","unstructured":"Xin L, Lin X, Pan Y, et al. A collagen scaffold loaded with human umbilical cord-derived mesenchymal stem cells facilitates endometrial regeneration and restores fertility. Acta Biomater. 2019;92:160\u201371.","journal-title":"Acta Biomater"},{"key":"1806_CR8","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s13287-018-0904-3","volume":"9","author":"Y Cao","year":"2018","unstructured":"Cao Y, Sun H, Zhu H, et al. Allogeneic cell therapy using umbilical cord MSCs on collagen scaffolds for patients with recurrent uterine adhesion: a phase I clinical trial. Stem Cell Res Ther. 2018;9:192.","journal-title":"Stem Cell Res Ther"},{"key":"1806_CR9","doi-asserted-by":"crossref","unstructured":"Watson N, Divers R, Kedar R, Mehindru A, Mehindru A, Borlongan MC, et.al. Discarded Wharton jelly of the human umbilical cord: a viable source for mesenchymal stromal cells. Cytotherapy. 2015; 17:18\u201324.","DOI":"10.1016\/j.jcyt.2014.08.009"},{"key":"1806_CR10","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1089\/scd.2014.0490","volume":"24","author":"MR Todeschi","year":"2015","unstructured":"Todeschi MR, El Backly R, Capelli C, Daga A, Patrone E, Introna M. Transplanted umbilical cord mesenchymal stem cells modify the in vivo microenvironment enhancing angiogenesis and leading to bone regeneration. Stem Cells Dev. 2015;24:1570\u201381.","journal-title":"Stem Cells Dev"},{"key":"1806_CR11","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s10529-014-1692-1","volume":"37","author":"F Ji","year":"2015","unstructured":"Ji F, Duan HG, Zheng CQ, Li J. Comparison of chloromethyl-dialkylcarbocyanine and green fluorescent protein for labeling human umbilical mesenchymal stem cells. Biotechnol Lett. 2015;37:437\u201347.","journal-title":"Biotechnol Lett"},{"key":"1806_CR12","doi-asserted-by":"publisher","first-page":"20130001","DOI":"10.1098\/rsfs.2013.0001","volume":"3","author":"F Progatzky","year":"2013","unstructured":"Progatzky F, Dallman MJ, Lo CC. From seeing to believing: labelling strategies for in vivo cell-tracking experiments. Interface focus. 2013;3:20130001.","journal-title":"Interface focus"},{"key":"1806_CR13","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.imlet.2015.06.006","volume":"168","author":"C Capelli","year":"2015","unstructured":"Capelli C, Pedrini O, Valgardsdottir R, Da Roit F, Golay J, Introna M. Clinical grade expansion of MSCs. Immunol Lett. 2015;168:222\u20137.","journal-title":"Immunol Lett"},{"key":"1806_CR14","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.jss.2012.11.009","volume":"183","author":"F Liu","year":"2013","unstructured":"Liu F, Zhu ZJ, Li P, He YL. Creation of a female rabbit model for intrauterine adhesions using mechanical and infectious injury. J Surg Res. 2013;183:296\u2013303.","journal-title":"J Surg Res"},{"key":"1806_CR15","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1159\/000479086","volume":"83","author":"D Kong","year":"2018","unstructured":"Kong D, Zhang L, Xu X, Zhang J, Li Y, Huang X. Small intestine submucosa is a potential material for intrauterine adhesions treatment in a rat model. Gynecol Obstet Investig. 2018;83:499\u2013507.","journal-title":"Gynecol Obstet Investig"},{"key":"1806_CR16","first-page":"35","volume-title":"Essential tools for morphometric studies of biological tissues: practical stereological methods","author":"ZW Yang","year":"2012","unstructured":"Yang ZW. Essential tools for morphometric studies of biological tissues: practical stereological methods. Bejing: Cornell University Press; 2012. p. 35\u20136."},{"key":"1806_CR17","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s13287-018-0924-z","volume":"9","author":"N Ebrahim","year":"2018","unstructured":"Ebrahim N, Mostafa O, El Dosoky RE, Ahmed IA, Saad AS, Mostafa A, et al. Human mesenchymal stem cell-derived extracellular vesicles\/estrogen combined therapy safely ameliorates experimentally induced intrauterine adhesions in a female rat model. Stem Cell Res Ther. 2018;9:175.","journal-title":"Stem Cell Res Ther"},{"key":"1806_CR18","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s13287-019-1368-9","volume":"10","author":"B Li","year":"2019","unstructured":"Li B, Zhang Q, Sun J, Lai D. Human amniotic epithelial cells improve fertility in an intrauterine adhesion mouse model. Stem Cell Res Ther. 2019;10:257.","journal-title":"Stem Cell Res Ther"},{"key":"1806_CR19","doi-asserted-by":"publisher","first-page":"200","DOI":"10.29252\/ibj.23.3.200","volume":"23","author":"L Jalalie","year":"2019","unstructured":"Jalalie L, Rezaie MJ, Jalili A, Rezaee MA, Vahabzadeh Z, Rahmani MR, et al. Distribution of the CM-Dil-labeled human umbilical cord vein mesenchymal stem cells migrated to the cyclophosphamide-injured ovaries in C57BL\/6 mice. Iran Biomed J. 2019;23:200\u20138.","journal-title":"Iran Biomed J"},{"key":"1806_CR20","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1179\/1743132814Y.0000000399","volume":"37","author":"J Ma","year":"2015","unstructured":"Ma J, Liu N, Yi B, Zang X, Gao B, Zhang Y, et al. Transplanted hUCB-MSCs migrated to the damaged area by SDF-1\/CXCR4 signaling to promote functional recovery after traumatic brain injury in rats. Neurol Res. 2015;37:50\u20136.","journal-title":"Neurol Res"},{"key":"1806_CR21","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1002\/stem.217","volume":"27","author":"L Zangi","year":"2009","unstructured":"Zangi L, Margalit R, Reich-Zeliger S, Bachar-Lustig E, Beilhack A, Negrin R, et al. Direct imaging of immune rejection and memory induction by allogeneic mesenchymal stromal cells. Stem Cells. 2009;27:2865\u201374.","journal-title":"Stem Cells"},{"key":"1806_CR22","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.nucmedbio.2011.03.008","volume":"38","author":"A Gholamrezanezhad","year":"2011","unstructured":"Gholamrezanezhad A, Mirpour S, Bagheri M, Mohamadnejad M, Alimoghaddam K, Abdolahzadeh L, et al. In vivo tracking of 111In-oxine labeled mesenchymal stem cells following infusion in patients with advanced cirrhosis. Nucl Med Biol. 2011;38:961\u20137.","journal-title":"Nucl Med Biol"},{"key":"1806_CR23","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.5966\/sctm.2015-0379","volume":"5","author":"EG Schmuck","year":"2016","unstructured":"Schmuck EG, Koch JM, Centanni JM, Hacker TA, Braun RK, Eldridge M, et al. Biodistribution and clearance of human mesenchymal stem cells by quantitative three-dimensional cryo-imaging after intravenous infusion in a rat lung injury model. Stem Cells Transl Med. 2016;5:1668\u201375.","journal-title":"Stem Cells Transl Med"},{"key":"1806_CR24","doi-asserted-by":"publisher","first-page":"865","DOI":"10.14348\/molcells.2014.0145","volume":"37","author":"J Liu","year":"2014","unstructured":"Liu J, Zhang H, Zhang Y, Li N, Wen Y, Cao F, Ai H, Xue X. Homing and restorative effects of bone marrow-derived mesenchymal stem cells on cisplatin injured ovaries in rats. Molecules and cells. 2014;37:865\u201372.","journal-title":"Molecules and cells"},{"key":"1806_CR25","first-page":"255","volume":"22","author":"N Auersperg","year":"2001","unstructured":"Auersperg N, Wong AS, Choi KC, Kang SK, Leung PC. Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr Rev. 2001;22:255\u201388.","journal-title":"Endocr Rev"},{"key":"1806_CR26","doi-asserted-by":"publisher","first-page":"18350","DOI":"10.1073\/pnas.0608861103","volume":"103","author":"O Wada-Hiraike","year":"2006","unstructured":"Wada-Hiraike O, Hiraike H, Okinaga H, Imamov O, Barros RP, Morani A, et al. Role of estrogen receptor beta in uterine stroma and epithelium: insights from estrogen receptor beta\u2212\/\u2212 mice. Proc Natl Acad Sci U S A. 2006;103:18350\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1806_CR27","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/j.1432-0436.2005.00033.x","volume":"73","author":"T Kurita","year":"2005","unstructured":"Kurita T, Medina R, Schabel AB, Young P, Gama P, Parekh TV, et al. The activation function-1 domain of estrogen receptor alpha in uterine stromal cells is required for mouse but not human uterine epithelial response to estrogen. Differentiation. 2005;73:313\u201322.","journal-title":"Differentiation."},{"key":"1806_CR28","doi-asserted-by":"publisher","first-page":"6535","DOI":"10.1073\/pnas.94.12.6535","volume":"94","author":"PS Cooke","year":"1997","unstructured":"Cooke PS, Buchanan DL, Young P, Setiawan T, Brody J, Korach KS, et al. Stromal estrogen receptors mediate mitogenic effects of estradiol on uterine epitheliu. Proc Natl Acad Sci U S A. 1997;94:6535\u201340.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1806_CR29","first-page":"4726","volume":"11","author":"LP Guo","year":"2019","unstructured":"Guo LP, Chen LM, Chen F, Jiang NH, Sui L. Smad signaling coincides with epithelial-mesenchymal transition in a rat model of intrauterine adhesion. Am J Transl Res. 2019;11:4726\u201337.","journal-title":"Am J Transl Res"},{"key":"1806_CR30","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jconrel.2019.12.007","volume":"318","author":"L Kou","year":"2020","unstructured":"Kou L, Jiang X, Xiao S, Zhao YZ, Yao Q, Chen R. Therapeutic options and drug delivery strategies for the prevention of intrauterine adhesions. J Control Release. 2020;318:25\u201337.","journal-title":"J Control Release"},{"key":"1806_CR31","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1093\/humrep\/dev156","volume":"30","author":"X Chen","year":"2015","unstructured":"Chen X, Liu J, He B, Li Y, Liu S, Wu B, et al. Vascular endothelial growth factor (VEGF) regulation by hypoxia inducible factor-1 alpha (HIF1A) starts and peaks during endometrial breakdown, not repair, in a mouse menstrual-like model. Hum Reprod. 2015;30:2160\u201370.","journal-title":"Hum Reprod"},{"key":"1806_CR32","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1530\/REP-16-0286","volume":"152","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Lin X, Dai Y, Hu X, Zhu H, Jiang Y. Endometrial stem cells repair injured endometrium and induce angiogenesis via AKT and ERK pathways. Reproduction. 2016;152:389\u2013402.","journal-title":"Reproduction."},{"key":"1806_CR33","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00403-018-1849-1","volume":"310","author":"G Wei","year":"2018","unstructured":"Wei G, Xu Q, Liu L, Zhang H, Tan X, Zhang CL, et al. Y2109761 reduces TGF-\u03b21-induced collagen production and contraction in hypertrophic scar fibroblasts. Arch Dermatol Res. 2018;310:615\u201323.","journal-title":"Arch Dermatol Res"},{"key":"1806_CR34","doi-asserted-by":"publisher","first-page":"4158287","DOI":"10.1155\/2016\/4158287","volume":"2016","author":"U Salma","year":"2016","unstructured":"Salma U, Xue M, Ali Sheikh MS, Guan X, Xu B, Zhang A, et al. Role of transforming growth factor-\u03b21 and Smads signaling pathway in intrauterine adhesion. Mediat Inflamm. 2016;2016:4158287.","journal-title":"Mediat Inflamm"},{"key":"1806_CR35","first-page":"2286","volume":"18","author":"J Ning","year":"2018","unstructured":"Ning J, Zhang H, Yang H. MicroRNA-326 inhibits endometrial fibrosis by regulating TGF-\u03b21\/Smad3 pathway in intrauterine adhesions. Mol Med Rep. 2018;18:2286\u201392.","journal-title":"Mol Med Rep"},{"key":"1806_CR36","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s11010-017-2940-1","volume":"429","author":"J Xuan","year":"2017","unstructured":"Xuan J, Feng W, An ZT, Yang J, Xu HB, Li J, et al. Anti-TGF\u03b2-1 receptor inhibitor mediates the efficacy of the human umbilical cord mesenchymal stem cells against liver fibrosis through TGF\u03b2-1\/Smad pathway. Mol Cell Biochem. 2017;429:113\u201322.","journal-title":"Mol Cell Biochem"},{"key":"1806_CR37","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3389\/fphar.2017.00461","volume":"8","author":"KL Walton","year":"2017","unstructured":"Walton KL, Johnson KE, Harrison CA. Targeting TGF-\u03b2 mediated SMAD signaling for the prevention of fibrosis. Front Pharmacol. 2017;8:461.","journal-title":"Front Pharmacol"},{"key":"1806_CR38","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.biopha.2018.02.090","volume":"101","author":"C Lin","year":"2018","unstructured":"Lin C, Yang T, Lu D-W, Zhao H, Feng Y-L, Chen H, et al. Central role of dysregulation of TGF-\u03b2\/Smad in CKD progression and potential targets of its treatment. Biomed Pharmacother. 2018;101:670\u201381.","journal-title":"Biomed Pharmacother"},{"key":"1806_CR39","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.3748\/wjg.v24.i16.1679","volume":"24","author":"E Hern\u00e1ndez-Aquino","year":"2018","unstructured":"Hern\u00e1ndez-Aquino E, Muriel P. Beneficial effects of Naringenin in liver diseases: molecular mechanisms. World J Gastroenterol. 2018;24:1679\u2013707.","journal-title":"World J Gastroenterol"},{"key":"1806_CR40","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4103\/sjg.SJG_297_17","volume":"24","author":"KM Cook","year":"2018","unstructured":"Cook KM, William D. Involvement of epithelial-mesenchymal transition in liver fibrosis. Saudi J Gastroenterol. 2018;24:5\u201311.","journal-title":"Saudi J Gastroenterol"},{"key":"1806_CR41","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3322\/caac.20075","volume":"60","author":"KM Cook","year":"2010","unstructured":"Cook KM, William D. Angiogenesis inhibitors-current strategies and future prospects. CA Cancer J Clin. 2010;60:222\u201343.","journal-title":"CA Cancer J Clin"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-020-01806-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-020-01806-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-020-01806-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T23:13:19Z","timestamp":1626131599000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-020-01806-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,13]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1806"],"URL":"https:\/\/doi.org\/10.1186\/s13287-020-01806-4","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,13]]},"assertion":[{"value":"26 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Research and Ethical Committee of the Second Hospital of Hebei Medical University, China, basing on the 1964 Helsinki Declaration and its later amendments.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"280"}}